BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37726802)

  • 21. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region.
    Sapp E; Seeley C; Iuliano M; Weisman E; Vodicka P; DiFiglia M; Kegel-Gleason KB
    Neurobiol Dis; 2020 Jul; 141():104950. PubMed ID: 32439598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease.
    Heikkinen T; Bragge T; Bhattarai N; Parkkari T; Puoliväli J; Kontkanen O; Sweeney P; Park LC; Munoz-Sanjuan I
    PLoS One; 2020; 15(12):e0243052. PubMed ID: 33370315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Molecule Pytren-4QMn Metal Complex Slows down Huntington's Disease Progression in Male zQ175 Transgenic Mice.
    Merino M; González S; Tronch MC; Sánchez-Sánchez AV; Clares MP; García-España A; García-España E; Mullor JL
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mGluR5 antagonism increases autophagy and prevents disease progression in the
    Abd-Elrahman KS; Hamilton A; Hutchinson SR; Liu F; Russell RC; Ferguson SSG
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
    Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
    Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.
    Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS
    J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease.
    van Dellen A; Cordery PM; Spires TL; Blakemore C; Hannan AJ
    BMC Neurosci; 2008 Apr; 9():34. PubMed ID: 18380890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
    Mo C; Renoir T; Hannan AJ
    Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease.
    Putkhao K; Kocerha J; Cho IK; Yang J; Parnpai R; Chan AW
    Stem Cells Dev; 2013 Apr; 22(8):1198-205. PubMed ID: 23190281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
    Giralt A; Puigdellívol M; Carretón O; Paoletti P; Valero J; Parra-Damas A; Saura CA; Alberch J; Ginés S
    Hum Mol Genet; 2012 Mar; 21(6):1203-16. PubMed ID: 22116937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.
    Lin MS; Liao PY; Chen HM; Chang CP; Chen SK; Chern Y
    J Neurosci; 2019 Feb; 39(8):1505-1524. PubMed ID: 30587542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington's Disease.
    Joshi T; Kumar V; Kaznacheyeva EV; Jana NR
    Mol Neurobiol; 2021 Aug; 58(8):3992-4006. PubMed ID: 33904021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington's disease knock-in mice.
    Brooks S; Higgs G; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):182-8. PubMed ID: 20457230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis.
    Dietrich P; Johnson IM; Alli S; Dragatsis I
    PLoS Genet; 2017 Jul; 13(7):e1006846. PubMed ID: 28715425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.
    Menalled L; El-Khodor BF; Patry M; Suárez-Fariñas M; Orenstein SJ; Zahasky B; Leahy C; Wheeler V; Yang XW; MacDonald M; Morton AJ; Bates G; Leeds J; Park L; Howland D; Signer E; Tobin A; Brunner D
    Neurobiol Dis; 2009 Sep; 35(3):319-36. PubMed ID: 19464370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bim contributes to the progression of Huntington's disease-associated phenotypes.
    Roberts SL; Evans T; Yang Y; Fu Y; Button RW; Sipthorpe RJ; Cowan K; Valionyte E; Anichtchik O; Li H; Lu B; Luo S
    Hum Mol Genet; 2020 Jan; 29(2):216-227. PubMed ID: 31813995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
    Nithianantharajah J; Hannan AJ
    Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.